A study observed that HNSCC patients with high expression of CD3 and CD8 T cells in their tumors benefited from longer overall survival, distant-metastasis-free survival, and progression-free survival compared to the patients with low expression of these TILs [104]. The gene discussed is CD8A; the disease is head and neck squamous cell carcinoma.